Does hepatitis C virus cause severe liver disease only in people who drink alcohol? (Q34683615)

3 August 2017

1 reference

title

Does hepatitis C virus cause severe liver disease only in people who drink alcohol? (English)

1 reference

3 August 2017

1 reference

1 reference

1 reference

Francesca Cainelli

2

0 references

Sandro Vento

object named as

Sandro Vento

series ordinal

1

0 references

publication date

1 May 2002

1 reference

Lancet Infectious Diseases

3 August 2017

1 reference

3 August 2017

2

1 reference

3 August 2017

5

1 reference

3 August 2017

303-309

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Hepatitis C virus antibodies among risk groups in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

1 reference

7 January 2021

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Natural history of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Prevalence of hepatitis B and C markers in the south-east of Spain: an unlinked community-based serosurvey of 2,203 adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Epidemiology of hepatitis C virus infection in an area of Southern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Hepatitis C infection in an Italian population not selected for risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in southern Italy: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Impact of hepatitis C virus infection on healthy subjects on an Italian island

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Community-based seroepidemiological survey of HCV infection in Catalonia, Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Natural history and etiology of liver disease in patients with previous community-acquired acute non-A, non-B hepatitis. A follow-up study of 178 Danish patients consecutively enrolled in The Copenhagen Hepatitis Acuta Programme in the period 1969-1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

45-year follow-up of hepatitis C virus infection in healthy young adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

The epidemiology of hepatitis C in a UK health regional population of 5.12 million

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Impact of alcohol on the histological and clinical progression of hepatitis C infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Role of alcohol in the progression of liver disease caused by hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Alcohol intake increases hepatitis C virus-induced hepatocellular injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

The effect of light drinking on HCV liver disease: the jury is still out.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma--its relationship to alcohol drinking and the age of transfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Drinking habits of subjects with hepatitis C virus-related chronic liver disease: prevalence and effect on clinical, virological and pathological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Influence of chronic alcohol abuse on hepatitis C virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Difference in quasispecies of the hypervariable region 1 of hepatitis C virus between alcoholic and non-alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Chronic hepatitis C is mild in menstruating women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Conference summary: Consensus Conference on Alcohol Dependence and the Role of Pharmacotherapy in its Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Female sex and the risk of liver cirrhosis. Collaborative Groups for the Study of Liver Diseases in Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Factors determining cirrhosis in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Excess weight risk factor for alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

The alcoholic patient with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Liver steatosis and chronic hepatitis C: a spurious association?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Hepatitis C is more severe in drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Clotting factor concentrates and immune function in haemophilic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

The progression of HCV-associated liver disease in a cohort of haemophilic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

The natural history of chronic hepatitis C in haemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Presence of HIV-1 in human parenchymal and non-parenchymal liver cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Role of endogenous interferon in hepatitis C virus (HCV) infection and in coinfection by HIV and HCV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Interactions between metabolic disorders (diabetes, gallstones, and dyslipidaemia) and the progression of chronic hepatitis C virus infection to cirrhosis and hepatocellular carcinoma. A cross-sectional multicentre survey

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Host genetic factors influence disease progression in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

The habitual diet in rural and urban Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Alcohol consumption amongst South African farm workers: a challenge for post-apartheid health sector transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

Alcohol consumption and mortality among middle-aged and elderly U.S. adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2802%2900271-2

7 January 2021

10.1016/S1473-3099(02)00271-2

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12062996